In order to explore the role of LHFPL3-AS1 in tumor progression in vivo, the melanoma stem cells transfected with LHFPL3-AS1-shRNA were subcutaneously injected into nude mice, followed by monitoring tumor growth every week for 6 weeks. This evidence concerns the gene LHFPL3 and melanoma.